ARCHIVES

Major Changes Being Considered By NCI For FCRA

This article is from The Cancer Letter archive.

Vol. 04 No. 15 | April 14, 1978

Download PDF Visit The Full Archive

Related Articles

No Benefit To Shark Cartilage As Treatment, Large Trial Finds

July 27, 2007

NCI Is Considering New Core Grants For Prostate, Breast Research Centers

April 19, 1991

DFA Proposes Controversial Guidelines For Clinical Tests

November 21, 1975

ASCO Calls For New Clinical Study Section, Endorses NCAB Action In Senate Testimony

July 23, 1993

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013

NCI Review Groups Merged Into One Umbrella Group

November 17, 1995